BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14675190)

  • 21. Proteases in Pemphigoid Diseases.
    Hiroyasu S; Turner CT; Richardson KC; Granville DJ
    Front Immunol; 2019; 10():1454. PubMed ID: 31297118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of subepidermal blistering disease with anti-p200 or 180-kD bullous pemphigoid antigen associated with psoriasis.
    Yasuda H; Tomita Y; Shibaki A; Hashimoto T
    Dermatology; 2004; 209(2):149-55. PubMed ID: 15316172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and function of basement membrane.
    Stanley JR; Woodley DT; Katz SI; Martin GR
    J Invest Dermatol; 1982 Jul; 79 Suppl 1():69s-72s. PubMed ID: 7086192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies.
    Leyendeckers H; Tasanen K; Bruckner-Tuderman L; Zillikens D; Sitaru C; Schmitz J; Hunzelmann N
    J Invest Dermatol; 2003 Mar; 120(3):372-8. PubMed ID: 12603849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 105-kDa basement membrane autoantigen p105 is N-terminally homologous to a tumor-associated antigen.
    Chan LS; Woodley DT
    J Invest Dermatol; 1996 Aug; 107(2):209-14. PubMed ID: 8757764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-laminin gamma-1 pemphigoid.
    Dainichi T; Kurono S; Ohyama B; Ishii N; Sanzen N; Hayashi M; Shimono C; Taniguchi Y; Koga H; Karashima T; Yasumoto S; Zillikens D; Sekiguchi K; Hashimoto T
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2800-5. PubMed ID: 19196964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bullous pemphigoid and related subepidermal autoimmune blistering diseases.
    Olasz EB; Yancey KB
    Curr Dir Autoimmun; 2008; 10():141-66. PubMed ID: 18460884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited.
    van Beek N; Dohse A; Riechert F; Krull V; Recke A; Zillikens D; Schmidt E
    Br J Dermatol; 2014 Apr; 170(4):943-7. PubMed ID: 24734947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granzyme B is elevated in autoimmune blistering diseases and cleaves key anchoring proteins of the dermal-epidermal junction.
    Russo V; Klein T; Lim DJ; Solis N; Machado Y; Hiroyasu S; Nabai L; Shen Y; Zeglinski MR; Zhao H; Oram CP; Lennox PA; Van Laeken N; Carr NJ; Crawford RI; Franzke CW; Overall CM; Granville DJ
    Sci Rep; 2018 Jun; 8(1):9690. PubMed ID: 29946113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An animal model of bullous pemphigoid: what can it teach us?
    Giudice GJ; Liu Z; Diaz LA
    Proc Assoc Am Physicians; 1995 Jul; 107(2):237-41. PubMed ID: 8624858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A severe and refractory case of anti-p200 pemphigoid resulting in multiple skin ulcers and scar formation.
    Goto-Ohguchi Y; Nishie W; Akiyama M; Tateishi Y; Aoyagi S; Tsuji-Abe Y; Sawamura D; Ishii N; Hashimoto T; Shimizu H
    Dermatology; 2009; 218(3):265-71. PubMed ID: 19060472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis.
    Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M
    Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
    Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
    J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of epidermal keratinocytes and dermal fibroblasts on the formation of cutaneous basement membrane in three-dimensional culture systems.
    Lee DY; Cho KH
    Arch Dermatol Res; 2005 Jan; 296(7):296-302. PubMed ID: 15650892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Localization of basement membrane components after dermal-epidermal junction separation.
    Woodley D; Sauder D; Talley MJ; Silver M; Grotendorst G; Qwarnstrom E
    J Invest Dermatol; 1983 Aug; 81(2):149-53. PubMed ID: 6348179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating IgA and IgE autoantibodies in antilaminin-332 mucous membrane pemphigoid.
    Natsuga K; Nishie W; Shinkuma S; Moriuchi R; Shibata M; Nishimura M; Hashimoto T; Shimizu H
    Br J Dermatol; 2010 Mar; 162(3):513-7. PubMed ID: 19751242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidermolysis bullosa acquisita: what's new?
    Ishii N; Hamada T; Dainichi T; Karashima T; Nakama T; Yasumoto S; Zillikens D; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida.
    Iwata H; Kitajima Y
    Exp Dermatol; 2013 Jun; 22(6):381-5. PubMed ID: 23651418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.